CN111481617A - Inhalant for treating herpes zoster and preparation method thereof - Google Patents

Inhalant for treating herpes zoster and preparation method thereof Download PDF

Info

Publication number
CN111481617A
CN111481617A CN202010552829.8A CN202010552829A CN111481617A CN 111481617 A CN111481617 A CN 111481617A CN 202010552829 A CN202010552829 A CN 202010552829A CN 111481617 A CN111481617 A CN 111481617A
Authority
CN
China
Prior art keywords
herpes zoster
croton
inhalant
chinese date
snake slough
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010552829.8A
Other languages
Chinese (zh)
Inventor
石婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010552829.8A priority Critical patent/CN111481617A/en
Publication of CN111481617A publication Critical patent/CN111481617A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles
    • A61K35/583Snakes; Lizards, e.g. chameleons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of medicines, relates to an inhalant for treating herpes zoster and also relates to a preparation method of the inhalant. The invention provides an inhalant for treating herpes zoster, which is prepared from the following raw materials: 10g to 30g of snake slough, 15g to 50g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, and 500ml to 1000ml of white spirit (more than 50 degrees). The weight ratio of each component is as follows: snake slough, croton, scallion and Chinese date are 1: 0.6-3: 1-3. According to the invention, according to the pathogenesis principle of herpes zoster, the medicament is ground by the volatile principle of alcohol and then is put into white spirit to be processed so as to maximize the efficacy of the medicament, and the medicament can be put into nasal cavities to achieve the effects of inducing resuscitation, removing heat, strengthening body resistance, eliminating dampness, tonifying middle-jiao and Qi, nourishing blood, soothing nerves and improving immunity.

Description

Inhalant for treating herpes zoster and preparation method thereof
The technical field is as follows:
the invention belongs to the technical field of medicines, relates to an inhalant for treating herpes zoster and also relates to a preparation method of the inhalant.
Background art:
herpes zoster is a clinically common viral skin disease and is called herpes zoster, herpes zoster or herpes zoster erysipelas in traditional Chinese medicine. Shingles is primarily due to clustered blisters and intense pain along the peripheral innervated area following varicella-zoster virus infection. The clinical characteristics of the onset of herpes zoster are that the elderly are more and people with low immunity are easy to get herpes zoster, and the bigger the age is, the more pain is, and the higher the probability of postherpetic neuralgia is. The virus can be latent in neurons of spinal nerve posterior root ganglia for a long time after invading nerve infection, and can grow and propagate to cause diseases when the resistance is low or the nerve is tired and infected, the cold is fever, and the vital energy is generated and the disease is developed. The traditional Chinese medicine considers that the liver-qi stagnation and the fire transformation are caused by the accumulation of damp-heat in the spleen channel and the overflow of the damp-heat out of the skin, or the liver-qi stagnation and the fire transformation are caused by the accumulation of damp-heat and toxin in the skin due to accidental infection. The elderly and infirm can usually have severe pain due to blood deficiency, liver hyperactivity, damp-heat toxicity and stagnation of qi and blood, and can disappear after a long time. The invention relates to a traditional Chinese medicine for treating herpes zoster, which is prepared by the steps of adding medicines into a nasal cavity to assist the healthy energy of a human body, wherein the healthy energy is sufficient, so that cold-dampness and air leakage cannot invade the human body, inducing resuscitation and transforming heat, diminishing inflammation and easing pain, strengthening the body resistance and clearing damp, promoting blood circulation and removing obstruction in channels, astringing dampness and promoting tissue regeneration and healing sore, tonifying middle-jiao and Qi, and improving immunity.
Most of the existing medicines for treating herpes zoster are antiviral medicines and nerve-nourishing medicines, such as acyclovir ointment, acyclovir tablets and pregabalin capsules (lerecan), the side effect is mainly the damage of the functions of the liver and the kidney, the analgesic medicines are central analgesics such as carbamazepine, amitriptyline and the like, although the central analgesics have better curative effect at that time and temporarily stop pain, the postherpetic neuralgia is prolonged at the later stage, and many central analgesics have dependence.
The invention content is as follows:
the invention aims to overcome the defects of the prior art and provide an inhalant for treating herpes zoster, which is applied through a nasal cavity without touching the body, not only can achieve the exact curative effect of treating herpes zoster, but also has the characteristic of reducing toxic and side effects.
The invention is realized by the following technical scheme:
the invention provides an inhalant for treating herpes zoster, which is prepared from the following raw materials:
10g to 30g of snake slough, 15g to 50g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, and 500ml to 1000ml of white spirit (more than 50 degrees).
Wherein the weight ratio of each component is as follows: snake slough, croton, shallot and Chinese date are 1: 0.6-3: 1-3, preferably 1: 1-3: 3, more preferably 1: 2: 3.
Further, the invention is preferably prepared from the following raw materials:
10g to 20g of snake slough, 15g to 30g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, and 500ml to 1000ml of white spirit (more than 50 degrees).
The weight ratio of each component is as follows: snake slough, croton, shallot and Chinese date are 1: 0.6-3: 1-3, preferably 1: 1-3: 3, more preferably 1: 2: 3.
Wherein, in the inhalant for treating herpes zoster, the components have the following functions:
snake slough: dispelling pathogenic wind, arresting convulsion, removing nebula, relieving swelling, and killing parasite; inducing resuscitation and dissipating heat, strengthening body resistance and eliminating dampness: "Yi Lin Du" (treatise on medilin) says that snake slough: "removing toxic heat and wind-damp", Snake slough is sweet and salty in flavor, sweet in flavor and capable of removing toxicity, salty in flavor can soften hardness and dissipate nodulation, enter liver and spleen meridians and enter blood system, so it can remove toxicity and relieve swelling.
Croton seed: removing blood stasis, resolving food stagnation, relieving pain, and resolving hard mass; astringe dampness, promote granulation, heal wound, diminish inflammation and relieve pain: croton, fructus crotonis, pungent in flavor and strongly toxic in property, enters stomach and large intestine meridians. For external use, it can corrode sore, and is suitable for treating malignant boil, scabies, tinea, and wart and nevus. Has effects in inhibiting bacterial growth, relieving pain, and treating carbuncle, cellulitis, malignant sore, furuncle, and sore.
Scallion: inducing sweat, relieving exterior syndrome, activating yang, and promoting urination; the scallion is pungent in flavor and slightly warm in nature, and has the effects of relieving exterior syndrome, activating yang, and detoxifying, and has the antibacterial, bactericidal and antiviral effects.
Chinese date: invigorating spleen and replenishing qi, nourishing blood and tranquillizing mind, and relieving drug property; tonify middle-jiao and qi, nourish blood and tranquilize: the Chinese dates are sweet in taste and warm in nature, enter spleen and stomach channels, have the effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and relieving drug properties, and saccharides in the Chinese dates mainly comprise glucose, fructose, cane sugar, oligosaccharide consisting of glucose and fructose, araban and galactan, contain a large amount of vitamin C, thiamine, carotene, nicotinic acid, riboflavin and other vitamins, have a strong nourishing effect, and can help a human body to improve the immunity and enhance the disease resistance.
The invention also provides a preparation method of the smelling agent, which comprises the following steps: cleaning the above Chinese medicinal materials, air drying, oven drying, pulverizing the Chinese medicinal materials with a Chinese medicinal pulverizer under aseptic and dustless conditions, sieving with 12 mesh sieve, mixing, adding into Chinese liquor, stirring, and sealing for 15-30 days.
According to the invention, according to the pathogenesis principle of herpes zoster, the medicament is ground by the volatile principle of alcohol and then is put into white spirit to be processed so as to maximize the efficacy of the medicament, and the medicament can be put into nasal cavities to achieve the effects of inducing resuscitation, removing heat, strengthening body resistance, eliminating dampness, tonifying middle-jiao and Qi, nourishing blood, soothing nerves and improving immunity.
The snuff takes 5 days as a treatment course, and is respectively smelled once every morning, noon and evening, and each time lasts for 20-30 minutes.
After the snake slough, the croton, the onion and the Chinese date are ground and soaked in the white spirit with the alcohol content of more than 50 degrees, the main active ingredients of the snake slough, the croton, the onion and the Chinese date are extracted and absorbed by nasal mucosa through the volatilization principle of alcohol, thereby playing a role. When the ratio of snake slough to croton, shallot to jujube is 1: 0.6-3: 1-3, its effective rate is above 50%, and when the ratio of snake slough to croton, shallot to jujube is 1: 1-3: 3, its effective rate is above 60%, and when the ratio of snake slough to croton, shallot to jujube is 1: 2: 3, its effective rate can be above 90%. The method is safe, nontoxic, effective and suitable for long-term administration. The traditional Chinese medicine composition is simple to prepare, has the effects of inducing resuscitation and dissipating heat, diminishing inflammation and easing pain, strengthening body resistance and eliminating dampness, promoting blood circulation and removing obstruction in channels, eliminating dampness and promoting tissue regeneration and healing sore, and fundamentally repairs neuralgia caused by herpes zoster.
The specific implementation mode is as follows:
example 1:
screening the components of the prescription:
and (3) prescription test:
according to the prescription, the maximum efficacy of the prescription is ensured, the best treatment effect on the herpes zoster is achieved, and two bottles of samples (the sample is divided into a sample b and a sample c) are compared and verified with a sample of the original formula a
1. a, sample: snake slough 10g-30g croton 15g-50g onion 30g-60g Chinese date 30g-60g white spirit (above 50 degree) 500ml-1000ml
2. b, sample preparation: snake slough 10g-30g onion 30g-60g Chinese date 30g-60g white spirit (above 50 degree) 500ml-1000ml
3. c, sample preparation: 15g to 50g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, 500ml to 1000ml of white spirit (more than 50 degrees)
a, sample: the weight ratio of snake slough, croton, shallot and Chinese date is 1: 2: 3;
b, sample preparation: the weight ratio of the snake slough to the scallion to the Chinese date is 1: 3;
c, sample preparation: the weight ratio of the croton, the onion and the Chinese date is 2: 3;
the components are mixed and mixed evenly according to the proportion, then the mixture is put into the white spirit and is stirred evenly and sealed for 30 days.
1. And (3) firstly, the patient performs a trial smelling on the sample b for 5 days, wherein the trial smelling times are respectively one time in the morning, at noon and at night, the trial smelling time is 20 minutes each time, and the detection result shows that the herpes zoster is obviously reduced after 5 days, but the reaction neuralgia of the patient is slightly reduced but is not obvious, and the phenomenon of herpes zoster neuralgia attack still occurs.
2. And (3) the patient performs examination and smelling on the sample c for 5 days, wherein the examination and smelling times are respectively one time in the morning, the noon and the evening, the examination and smelling time is 20 minutes each time, and the examination result shows that the herpes zoster is slightly reduced after 5 days, but the herpes zoster is not obvious, the pain of the patient in response to the herpes zoster neuralgia outbreak is relieved, and the outbreak frequency is reduced.
3. Finally, the patient performs trial smelling on the sample a for 5 days, wherein the trial smelling times are respectively one time in the morning, at noon and at night, the trial smelling time is 20 minutes each time, and the patient has a very satisfactory effect on the sample after 5 days, so that the herpes zoster is obviously reduced, the pain feeling of the herpes zoster neuralgia outbreak is obviously relieved, and the outbreak frequency is obviously reduced.
The result shows that the inhalant has the functions of inducing resuscitation, dissipating heat, strengthening body resistance, eliminating dampness, promoting granulation, healing sore, diminishing inflammation, relieving pain, strengthening the middle-jiao, benefiting qi, nourishing blood, tranquilizing mind, inducing sweat, relieving exterior syndrome, activating yang and promoting urination, and has obvious treatment effect on herpes zoster.
Example 2:
in order to further prove the medicine property of the smelling agent, the maximum treatment effect of the medicine is determined by adjusting the medicine proportion of the smelling agent:
a, sample: the weight ratio of the snake slough to the croton, the scallion to the Chinese date is 1.5: 1: 1.5
b, sample preparation: the weight ratio of snake slough, croton, scallion and Chinese date is as follows: 1: 1.5
c, sample preparation: the weight ratio of snake slough, croton, scallion and Chinese date is as follows: 1: 2: 3
d, sample: the weight ratio of snake slough, croton, scallion and Chinese date is as follows: 1: 3
e, sample preparation: the weight ratio of snake slough, croton, scallion and Chinese date is as follows: 1: 3
In the test, 100 herpes zoster patients are selected to test 20 persons in each group of 5 groups of samples including a sample a, a sample b, a sample c, a sample d and a sample e, 5 days are taken as 1 test period, the test frequency is respectively one time in the morning, the evening and the test time is 20 minutes each time, and the test results are as follows:
a, sample: the number of patients with significantly reduced herpes zoster status was 10, 50% of the trial population in group a
b, sample preparation: the number of patients with significantly reduced herpes zoster status was 8, 40% of the test population in group b
c, sample preparation: the number of patients with significantly reduced herpes zoster status was 18, 90% of the test population in group c
d, sample: the number of patients with significantly reduced herpes zoster status was 12, accounting for 60% of the d groups tested
e, sample preparation: the number of patients with significantly reduced herpes zoster status was 13, 65% of the test subjects in group e
The 5 groups of experiments prove that the optimum preparation ratio of the snake slough, the croton, the onion and the Chinese date in the weight ratio of 1: 2: 3 can maximize the drug potency of the inhalant and has the most obvious curative effect on herpes zoster.

Claims (8)

1. An inhalant for treating herpes zoster is characterized by being prepared from the following raw materials:
10g to 30g of snake slough, 15g to 50g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, and 500ml to 1000ml of white spirit with the alcohol degree of more than 50.
2. The snuff for treating herpes zoster according to claim 1, wherein the snuff is prepared from the following raw materials:
10g to 20g of snake slough, 15g to 30g of croton, 30g to 60g of scallion, 30g to 60g of Chinese date, and 500ml to 1000ml of white spirit with the alcohol degree of more than 50.
3. The inhalant for treating herpes zoster according to claim 1 or 2, wherein the weight ratio of snake slough, croton, shallot and Chinese date is 1: 0.6-3: 1-3.
4. The inhalant for treating herpes zoster according to claim 1 or 2, wherein the weight ratio of snake slough, croton, shallot and Chinese date is 1: 1-3: 3.
5. An inhalant for treating herpes zoster according to claim 1 or 2, wherein the weight ratio of snake slough, croton, shallot and Chinese date is 1: 2: 3.
6. The method for preparing the snuff for treating herpes zoster according to any one of claims 1-5, wherein snake slough, croton, shallot and Chinese date are cleaned, air-dried, oven-dried, respectively pulverized by a Chinese medicinal pulverizer under aseptic and dustless conditions, mixed uniformly according to a certain proportion, put into white spirit, stirred uniformly and sealed for 15-30 days.
7. Use of an olfactory agent for the treatment of herpes zoster according to any one of claims 1 to 5 in the manufacture of a medicament for the treatment of herpes zoster.
8. The use of claim 7, wherein the composition is administered once a day, 20-30 minutes each time, in the morning, in the evening.
CN202010552829.8A 2020-06-17 2020-06-17 Inhalant for treating herpes zoster and preparation method thereof Pending CN111481617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010552829.8A CN111481617A (en) 2020-06-17 2020-06-17 Inhalant for treating herpes zoster and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010552829.8A CN111481617A (en) 2020-06-17 2020-06-17 Inhalant for treating herpes zoster and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111481617A true CN111481617A (en) 2020-08-04

Family

ID=71791011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010552829.8A Pending CN111481617A (en) 2020-06-17 2020-06-17 Inhalant for treating herpes zoster and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111481617A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103463339A (en) * 2013-09-12 2013-12-25 徐茂恺 Chinese patent medicine for treating herpes zoster

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103463339A (en) * 2013-09-12 2013-12-25 徐茂恺 Chinese patent medicine for treating herpes zoster

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
吴光利: "《中华医魂 医师篇》", 30 November 2004, 中医古籍出版社 *
张明海: "《吃好每天3顿饭》", 31 December 2012, 天津科学技术出版社 *
王慕同: "《皮肤科常见病自我饮食调治》", 31 January 2003, 人民军医出版社 *
贾克琳等: "《傣医方剂学》", 30 November 2007, 中国中医药出版社 *
陈馥馨: "《简明家庭中医药便览》", 31 July 1997, 中医古籍出版社 *

Similar Documents

Publication Publication Date Title
CN105362295A (en) Periplaneta americana pharmaceutical composition for treating acute and chronic faucitis and dental ulcers and preparation method thereof
CN110652544A (en) Pharmaceutical composition for treating rhinitis and preparation method thereof
CN107412640B (en) External ointment for assisting acupuncture and moxibustion physiotherapy
CN104524174A (en) Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof
CN111481617A (en) Inhalant for treating herpes zoster and preparation method thereof
CN1883679A (en) Medicine for treating pulmonary tuberculosis
CN1281228C (en) Medicine for hyperplasia of mammary glands and its preparation
CN111419924A (en) A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device
CN105477597A (en) Traditional Chinese medicinal composition for treating osteoidosteoma and preparation method of traditional Chinese medicinal composition
CN111821413A (en) Traditional Chinese medicine composition for treating diarrhea and hypodynamia as well as preparation and application thereof
CN101229193A (en) External Chinese patent medicine for treating skin ulceration and organism gangrene
CN114042109B (en) Traditional Chinese medicine composition and patch for inducing resuscitation and stopping nasal discharge, warming yang and strengthening body resistance and preparation method
NL2037306B1 (en) A nutritional product for clearing and protecting the lungs and a preparation method thereof
CN116115681B (en) Formula and method for preparing medicament for treating tonsillitis
CN103285182B (en) External-use ointment for treating skin diseases and preparation method thereof
CN109045218B (en) Yao medicine composition for preventing and treating upper respiratory inflammation and preparation method thereof
CN101502611B (en) Medicament for treating cancer and preparation method thereof
CN106620160A (en) Traditional Chinese medicine composition for treating bone fracture and preparation method of traditional Chinese medicine composition
CN105456537A (en) External medicine for treating gouty arthritis
CN104887808A (en) Periodontitis treatment traditional Chinese medicine preparation
CN104815293A (en) Traditional Chinese medicine tablet for treating otitis media and preparation method thereof
CN118252909A (en) Traditional Chinese medicine composition for treating auricular herpes zoster and application thereof
CN104800580A (en) Chinese medicinal prescription for treating amygdalitis
CN105412395A (en) Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof
CN116870055A (en) Traditional Chinese medicine composition for treating herpes zoster and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200804

RJ01 Rejection of invention patent application after publication